An announcement from SoftOx Solutions AS ( (DE:6FV) ) is now available.
SoftOx Solutions AS has completed a share capital increase through a private placement and debt conversion, resulting in a new share capital of NOK 44,808,339.88. This strategic move is expected to strengthen the company’s financial position and potentially enhance its market presence in the pharmaceutical industry.
More about SoftOx Solutions AS
SoftOx Solutions AS is a pharmaceutical company listed on Euronext Growth Oslo under the ticker ‘SOFTX’. Founded in 2012 and headquartered in Oslo, the company focuses on developing a highly effective antimicrobial solution for biofilm, viral, and antimicrobial-resistant infections. The company’s technology is patent-protected and developed in collaboration with leading Nordic research institutes.
Technical Sentiment Signal: Buy
Current Market Cap: €7.93M
For detailed information about 6FV stock, go to TipRanks’ Stock Analysis page.